Raymond James Financial Services Advisors Inc. cut its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 229,821 shares of the pharmacy operator’s stock after selling 19,990 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Walgreens Boots Alliance were worth $16,690,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Hudock Capital Group LLC increased its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Westside Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 125 shares during the period. Zions Bancorporation increased its stake in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,239 shares during the period. IHT Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 2,199 shares during the period. Finally, Bristlecone Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance in the third quarter valued at about $135,000. Hedge funds and other institutional investors own 60.82% of the company’s stock.
Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $70.91 on Wednesday. Walgreens Boots Alliance Inc has a one year low of $63.82 and a one year high of $88.00. The company has a market capitalization of $70,250.00, a P/E ratio of 19.59, a P/E/G ratio of 1.19 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. During the same quarter last year, the firm posted $1.10 earnings per share. The firm’s revenue was up 7.9% on a year-over-year basis. analysts forecast that Walgreens Boots Alliance Inc will post 5.73 EPS for the current fiscal year.
Walgreens Boots Alliance announced that its Board of Directors has approved a share buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s board believes its stock is undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $1.60 annualized dividend and a yield of 2.26%. Walgreens Boots Alliance’s dividend payout ratio is currently 44.20%.
In other news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 15th. The stock was purchased at an average price of $76.07 per share, with a total value of $7,520,128.06. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 14.80% of the company’s stock.
Several equities research analysts have recently weighed in on the company. Needham & Company LLC reissued a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, October 26th. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, Citigroup decreased their price target on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. Ten research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $85.37.
TRADEMARK VIOLATION WARNING: This piece of content was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thelincolnianonline.com/2018/02/21/raymond-james-financial-services-advisors-inc-reduces-holdings-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.